Koyfin Home > Directory > Health Care > Novocure Ltd Ord Sh > Capital Expenditures

Novocure Ltd Ord Sh Capital Expenditures Chart (NVCR)

Novocure Ltd Ord Sh annual/quarterly Capital Expenditures from 2014 to 2020.
  • Novocure Ltd Ord Sh Capital Expenditures for the quarter ending September 09, 2020 was $-3m a -9.81% increase of 0m year over year
  • Novocure Ltd Ord Sh Capital Expenditures for the last 12 months ending September 09, 2020 was $-12m a 14.51% decrease of -2m year over year
  • Novocure Ltd Ord Sh Annual Capital Expenditures for 2019 was $-10m a 35.99% decrease of -4m from 2018
  • Novocure Ltd Ord Sh Annual Capital Expenditures for 2018 was $-7m a -9.76% increase of 1m from 2017
  • Novocure Ltd Ord Sh Annual Capital Expenditures for 2017 was $-7m a -139.79% increase of 10m from 2016
Other Cash Flow Metrics:
  • Novocure Ltd Ord Sh Cash Flow from Operations for the quarter ending September 09, 2018 was $6m a 151.40% increase of 9m year over year
  • Novocure Ltd Ord Sh Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $11m a 57.24% increase of 6m year over year
  • Novocure Ltd Ord Sh Total Revenue for the quarter ending September 09, 2018 was $65m a 17.13% increase of 11m year over year
View Chart On Koyfin

Quarterly NVCR Capital Expenditures Data

09/2020$-3m
06/2020$-3m
03/2020$-3m
12/2019$-3m
09/2019$-3m
06/2019$-2m
03/2019$-2m
12/2018$-2m
09/2018$-1m
06/2018$-1m

Annual NVCR Capital Expenditures Data

2019$-10m
2018$-7m
2017$-7m
2016$-18m
2015$-10m
2014$-2m
2013$-4m